Fundraising FoxXCR Diagnostics
Salt Lake City, US · Utah corporation
Find your way into XCR Diagnostics
Sign up to see every warm intro you have to XCR Diagnostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the XCR Diagnostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
XCR Diagnostics develops portable molecular diagnostic systems for rapid nucleic acid testing at the point of care. The Pyramid system delivers lab-quality results in approximately 7 minutes for infectious disease detection in hospitals, clinics, emergency rooms, and resource-limited settings.
Founders & leadership
Reported raises · per SEC filings
Form D private placements$4.3M disclosed across 2 rounds · 2016–2019
▶$1.8MraisedOct 2019 · 20 investors · BiotechnologyRule 506(b)
▶$1.8MraisedOct 2019 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mark PowelsonExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.8M
- Proceeds to insiders
- $50K
- First sale
- Sep 2019
- Incorporated
- Corporation, Utah
- Federal exemptions
- 06b
▶$2.5MraisedDec 2016 · BiotechnologyRule 506(b)
▶$2.5MraisedDec 2016 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mark PowelsonExecutive Officer, Director
- Brian CaplinExecutive Officer, Promoter
- Ann Marie BuoscioExecutive Officer
- Linda MerrillDirector
- Mark BagnallDirector
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- Minimum investment
- $20K
- Sales commissions
- $250K
- Proceeds to insiders
- $500K
- Placement agents
- ACAP Financial Inc
- First sale
- Mar 2016
- Incorporated
- Corporation, Utah, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does XCR Diagnostics do?
- XCR Diagnostics develops portable molecular diagnostic systems for rapid nucleic acid testing at the point of care. The Pyramid system delivers lab-quality results in approximately 7 minutes for infectious disease detection in hospitals, clinics, emergency rooms, and resource-limited settings.
- How much funding has XCR Diagnostics raised?
- XCR Diagnostics has disclosed $4.3M raised across 2 rounds.
- Where is XCR Diagnostics headquartered?
- XCR Diagnostics is headquartered in Salt Lake City, US.